Cargando…

Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas

Type 1 diabetes (T1D) has been associated with both genetic and environmental factors. Increasing incidence of T1D worldwide is prompting researchers to adopt different approaches to explain the biology of T1D, beyond the presence and activity of autoreactive lymphocytes. In this review, we propose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jean-Baptiste, Virginie S.E., Xia, Chang-Qing, Clare-Salzler, Michael J., Horwitz, Marc S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552106/ https://www.ncbi.nlm.nih.gov/pubmed/28663145 http://dx.doi.org/10.1016/j.ebiom.2017.06.014

Ejemplares similares

Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Covid-19–Associated Myopathy Caused by Type I Interferonopathy
por: Manzano, Giovanna S., et al.
Publicado: (2020)

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
por: Meuwissen, Marije E.C., et al.
Publicado: (2016)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype
por: Clarke, S. L. N., et al.
Publicado: (2020)

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023)

Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib
por: Zhang, Shiyu, et al.
Publicado: (2021)

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2
por: Zhu, Gaofeng, et al.
Publicado: (2023)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
por: Goldmann, Tobias, et al.
Publicado: (2016)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

The pancreas in human type 1 diabetes
por: Rowe, Patrick A., et al.
Publicado: (2010)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)
por: Kanazawa, Nobuo, et al.
Publicado: (2023)

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
por: Gruber, Conor, et al.
Publicado: (2020)

Mast Cells and the Pancreas in Human Type 1 and Type 2 Diabetes
por: Masini, Matilde, et al.
Publicado: (2021)

Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic Mice
por: Looney, Ben M, et al.
Publicado: (2014)

The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
por: Davoodi-Semiromi, Abdoreza, et al.
Publicado: (2012)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes
por: Morse, Zachary J., et al.
Publicado: (2021)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
por: Duncan, Christopher James Arthur, et al.
Publicado: (2021)

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
por: Li, Wendao, et al.
Publicado: (2022)

Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes
por: Kattner, Nicole
Publicado: (2023)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response
por: Du, Hekang, et al.
Publicado: (2023)

Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes
por: Cobelli, Claudio, et al.
Publicado: (2012)

Virus induced dysbiosis promotes type 1 diabetes onset
por: Morse, Zachary J., et al.
Publicado: (2023)

Pancreas β cell regeneration and type 1 diabetes (Review)
por: WU, JINXIAO, et al.
Publicado: (2015)

Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
por: Brusko, Todd M., et al.
Publicado: (2021)

Robust controller for artificial pancreas for patients with type-1 diabetes
por: Mandal, Sharmistha, et al.
Publicado: (2023)

Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset
por: Morse, Zachary J., et al.
Publicado: (2017)

A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_fqv1o6klf5oean9qbn4nuo20dm